Affiliation:
1. MBBS, MS (Glaucoma Consultant), Professor, Department Of Ophthalmology, JJM Medical College, Davangere-577004.
2. Junior Resident, Department Of Ophthalmology, JJM Medical College, Davangere577004.
Abstract
Glaucoma is the leading cause of irreversible blindness in the world. Being a progressive optic neuropathy,
understanding multiple mechanisms playing a part in its progression is of vital importance. Among them, vascular theory
states that it occurs as a consequence of insufcient blood supply. To know if this insufciency occurs due to thrombosis in the blood vessels,
platelet aggregation parameters can be used as a guide.
Aims: To compare the association between platelet aggregation parameters in patients with and without primary open angle glaucoma and also
to co-relate it with the severity of glaucoma.
Design: Randomized, Cross-sectional, hospital-based observational study.
Methods: A total 53 consecutive patients with POAG and 53 controls were recruited in the study.
The cases were grouped as mild, moderate and severe based on the clinical optic nerve head ndings and mean deviation (MD) value of visual
elds. In bilateral cases, the eye with worse MD was selected.
Complete blood count was done to assess Platelet count (PLT), Platelet distribution width (PDW), Plateletcrit (PCT), Mean platelet volume
(MPV). These platelet aggregation parameters were compared between the two groups.
Results: In the POAG group, PDW (16.29±1.10 fL) and MPV (8.48±0.83 fL) values were signicantly higher (p <0.05) than those of the control
group (PDW 15.85±0.74 fL, MPV 8.17±0.76 fL). In POAG patients, PLT counts were lower (276.1±43.5) compared to controls (291.2±53.0)
though not statistically signicant. MPV (8.80±0.55), PDW (16.65±1.25) was highest in the moderate group but no statistically signicance
found.
Conclusions: PDW and MPV values were found to be higher in POAG patients, suggesting the possibility of platelet activation and hence
increased platelet aggregation leading to insufcient blood supply to the optic nerve head and hence development of POAG. Role of antiplatelet
drugs in delaying the development of glaucoma can be considered based on the above evidence.